Clinical Trial Update: Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating chronic intermittent intravenous insulin therapy for diabetic nephropathy and diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Diabetic Retinopathy

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Joslin Diabetes Center | Conditions: Diabetic Nephropathy, Diabetic Retinopathy | Phase 3 | Status: COMPLETED